Cheers Oslo, BRIAN70,
I agree that scale up is critical and certain to be an absolute deal breaker for any company wanting to incorporate M&G, they have to have complete confidence that using M&G won't effect stability or any other aspect of the test negatively - although it does sound like incorporating it into existing systems is relatively straightforward. Perhaps Biotech can offer more detail on the practicalities, risks and advantages of large volume M&G use?
bill gates foundation press release , page-11
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
